A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

November 30, 2027

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

CAL101

Intravenous infusions of CAL101 every 4 weeks over 24 weeks

DRUG

Placebo

Intravenous infusions of placebo every 4 weeks over 24 weeks

Trial Locations (47)

1478

RECRUITING

Akershus University Hospital, Lørenskog

5000

RECRUITING

Odense University Hospital, Odense

5021

RECRUITING

Haukeland University Hospital, Bergen

8200

RECRUITING

Aarhus University Hospital, Aarhus

13620

RECRUITING

Seoul National University Bundang Hospital, Gyeonggi-do

15706

NOT_YET_RECRUITING

Hospital Clinico Universitario de Santiago, Santiago de Compostela

16059

NOT_YET_RECRUITING

Uludag University Medical Faculty, Bursa

16499

RECRUITING

Ajou University Hospital, Suwon

19140

NOT_YET_RECRUITING

Temple University Hospital, Philadelphia

20089

NOT_YET_RECRUITING

Istituto Clinico Humanitas - Pneumologia 1, Rozzano

27103

RECRUITING

Southeastern Research Center, Winston-Salem

27403

RECRUITING

Pulmonix, LLC, Greensboro

33144

RECRUITING

Y & L Advance Health Care, Inc. d/b/a Elite Clinical Research, Miami

34149

RECRUITING

Azienda sanitaria universitaria Giuliano Isontina (ASU GI) - Ospedale di Cattinara, Trieste

35100

NOT_YET_RECRUITING

Ege University Medical Faculty Hospital, Izmir

35128

RECRUITING

Azienda Ospedale - Università Padova, Padua

37000

NOT_YET_RECRUITING

CHRU de Tours - Hôpital Bretonneau, Tours

39008

NOT_YET_RECRUITING

Hospital Universitario Marqués de Valdecilla, Santander

53100

RECRUITING

Azienda Ospedaliero Universitaria Senese, Siena

66160

NOT_YET_RECRUITING

University of Kansas Medical Center, Kansas City

80131

RECRUITING

Clinica di Malattie Respiratorie Università degli studi di Napoli Federico II, Napoli

80206

RECRUITING

National Jewish Health, Denver

84108

RECRUITING

University of Utah Health, Salt Lake City

90033

RECRUITING

Keck School of Medicine at USC, Los Angeles

93000

NOT_YET_RECRUITING

AP-HP Hopital Avicenne, Bobigny

200515

RECRUITING

Spitalul Clinic de Boli Infectioase si Pneumoftiziologie ''Victor Babes'' Craiova, Craiova

300310

RECRUITING

Spitalul Clinic de Boli Infectioase si Pneumoftiziologie dr. Victor Babes Timisoara, Timișoara

400371

RECRUITING

Spitalul Clinic de Pneumoftiziologie ''Leon Daniello'', Cluj-Napoca

31059 Cedex 9

NOT_YET_RECRUITING

CHU de Toulouse - Hopital Larrey, Toulouse

00168

RECRUITING

Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma

3015 GD

NOT_YET_RECRUITING

Erasmus MC, Rotterdam

3435 CM

RECRUITING

St. Antonius Ziekenhuis - Locatie Nieuwegein, Nieuwegein

0372

RECRUITING

Oslo University Hospital, Rikshospitalet, Oslo

050159

RECRUITING

Institutul de Pneumoftiziologie Marius Nasta, Bucharest

03080

RECRUITING

Seoul National University Hospital, Seoul

03722

RECRUITING

Severance Hospital, Yonsei University Health System, Seoul

05505

RECRUITING

Asan Medical Center, Seoul

08025

NOT_YET_RECRUITING

Hospital de la Santa Creu i Sant Pau, Barcelona

08035

RECRUITING

Hospital Universitario Vall d'Hebron, Barcelona

06010

RECRUITING

University of Health Sciences Gulhane Faculty of Medicine, Ankara

B15 2GW

NOT_YET_RECRUITING

Queen Elizabeth Hospital Birmingham, Birmingham

B9 5SS

NOT_YET_RECRUITING

Birmingham Heartlands Hospital, Birmingham

EH16 4SA

NOT_YET_RECRUITING

NHS Lothian, Edinburgh Royal Infirmary, Edinburgh

LS9 7TF

NOT_YET_RECRUITING

Leeds Teaching Hospitals NHS Trust, Leeds

SW3 6HP

RECRUITING

Royal Brompton Hospital, London

M23 9QZ

RECRUITING

Manchester University NHS Foundation Trust, Manchester

OX3 7LE

NOT_YET_RECRUITING

Oxford University Hospitals NHS Foundation Trust, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Calluna Pharma AS

INDUSTRY

NCT06736990 - A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter